Filing Details
MapLight Therapeutics, Inc. (NASDAQ:MPLT) filed a Form 8-K with the Securities and Exchange Commission on June 24, 2026, disclosing a material event.
8k filedNASDAQ:MPLT
MapLight Therapeutics, Inc. (MPLT) Reports Material Event to SEC
Filing Details MapLight Therapeutics, Inc. (NASDAQ:MPLT) filed a Form 8-K with the Securities and Exchange Commission on June 24, 2026, disclosing a material event. Market Context…
Market Context
MapLight Therapeutics, Inc.'s stock currently trades at $30.65 with a market capitalization of $15.9M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for MapLight Therapeutics, Inc.'s stock.
All SEC filings for MapLight Therapeutics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View MPLT Stock Page
Frequently Asked Questions
Where can I read MPLT's SEC filings?
Browse all filings on our MPLT SEC filings page.
What types of SEC filings does MapLight Therapeutics, Inc. file?
Public companies like MapLight Therapeutics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.